ICAP Antibodies

Santa Cruz Biotechnology features a diverse variety of ICAP Antibodies for studying intercellular adhesion molecule-1 (ICAM-1) in multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ICAM-1 plays a critical role in the immune response by facilitating the adhesion of leukocytes to endothelial cells, which is essential for inflammation and immune surveillance. Its expression increases in response to inflammatory cytokines, making ICAM-1 significant in various pathological conditions, including autoimmune diseases and cancer. Understanding ICAM-1 function and regulation opens new possibilities for therapeutic strategies targeting immune responses. ICAM-1 research continues to reveal important insights about cellular communication during immune responses. Ongoing studies of ICAM-1 contribute to our understanding of inflammatory processes and potential therapeutic interventions. Advanced research techniques and protocols enable precise detection and analysis of ICAM-1 expression patterns and interactions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of ICAM-1's role in human health and disease.